AAUM (Average Assets Under Management) of ₹538.60 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 68.5% | 72.7% | ▲ +4.2% |
| Healthcare Services | 17.5% | 17.2% | ▼ -0.3% |
| Insurance | 7.3% | 5.4% | ▼ -1.8% |
| IT - Services | 1.5% | 1.5% | ● 0.0% |
| Retailing | 1.7% | 1.2% | ▼ -0.5% |
| Healthcare Equipment & Supplies | 1.0% | 0.0% | ▼ -1.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 72.7% | 72.1% | ▼ -0.5% |
| Healthcare Services | 17.2% | 19.7% | ▲ +2.5% |
| Insurance | 5.4% | 2.3% | ▼ -3.2% |
| IT - Services | 1.5% | 1.4% | ▼ -0.1% |
| Retailing | 1.2% | 1.1% | ● -0.1% |
Comparing Jun 2026 → Jul 2026
| # | Stock | Sector | Weight (Jul 2026) |
|---|---|---|---|
| 1 | Manipal Health Enterprises Ltd ₹5.00 Cr |
Healthcare Services | 0.96% |
| # | Stock | Sector | Last Weight (Jun 2026) |
|---|---|---|---|
| 1 | JB Chemicals & Pharmaceuticals Limited ₹25.25 Cr |
Pharmaceuticals & Biotechnology | 4.57% |
| 2 | SBI Life Insurance Company Limited ₹17.66 Cr |
Insurance | 3.19% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Torrent Pharmaceuticals Limited ₹44.57 Cr |
Pharmaceuticals & Biotechnology | 5.43% | 8.58% | +3.15% |
| 2 | Divi's Laboratories Limited ₹34.58 Cr |
Pharmaceuticals & Biotechnology | 5.35% | 6.66% | +1.31% |
| 3 | Sun Pharmaceutical Industries Limited ₹45.83 Cr |
Pharmaceuticals & Biotechnology | 7.58% | 8.82% | +1.24% |
| 4 | Dr. Lal Path Labs Limited ₹16.19 Cr |
Healthcare Services | 2.53% | 3.12% | +0.59% |
| 5 | Apollo Hospitals Enterprise Limited ₹27.77 Cr |
Healthcare Services | 4.87% | 5.35% | +0.48% |
| 6 | Abbott India Limited ₹12.51 Cr |
Pharmaceuticals & Biotechnology | 2.07% | 2.41% | +0.34% |
| 7 | Concord Biotech Limited ₹10.66 Cr |
Pharmaceuticals & Biotechnology | 1.74% | 2.05% | +0.31% |
| 8 | Glenmark Pharmaceuticals Limited ₹17.87 Cr |
Pharmaceuticals & Biotechnology | 3.19% | 3.44% | +0.25% |
| 9 | Fortis Healthcare Limited ₹23.63 Cr |
Healthcare Services | 4.32% | 4.55% | +0.23% |
| 10 | Aurobindo Pharma Limited ₹15.80 Cr |
Pharmaceuticals & Biotechnology | 2.85% | 3.04% | +0.19% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Emcure Pharmaceuticals Limited ₹12.76 Cr |
Pharmaceuticals & Biotechnology | 3.60% | 2.46% | -1.14% |
| 2 | Laurus Labs Limited ₹27.24 Cr |
Pharmaceuticals & Biotechnology | 6.31% | 5.24% | -1.07% |
| 3 | Ajanta Pharma Limited ₹7.28 Cr |
Pharmaceuticals & Biotechnology | 1.95% | 1.40% | -0.55% |
| 4 | Acutaas Chemicals Ltd ₹11.19 Cr |
Pharmaceuticals & Biotechnology | 2.30% | 2.15% | -0.15% |
| 5 | Dr. Reddy's Laboratories Limited ₹5.74 Cr |
Pharmaceuticals & Biotechnology | 1.23% | 1.11% | -0.12% |
| 6 | Lupin Limited ₹33.57 Cr |
Pharmaceuticals & Biotechnology | 6.56% | 6.46% | -0.10% |
| 7 | Nephrocare Health Services Ltd ₹9.03 Cr |
Healthcare Services | 1.84% | 1.74% | -0.10% |
| 8 | Inventurus Knowledge Solutions Limited ₹7.40 Cr |
IT - Services | 1.52% | 1.42% | -0.10% |
| 9 | IPCA Laboratories Limited ₹29.71 Cr |
Pharmaceuticals & Biotechnology | 5.80% | 5.72% | -0.08% |
| 10 | MedPlus Health Services Limited ₹5.64 Cr |
Retailing | 1.17% | 1.09% | -0.08% |
30 stocks — Jul 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹45.83 Cr |
Pharmaceuticals & Biotechnology |
8.82%
|
|
| 2 |
₹44.57 Cr |
Pharmaceuticals & Biotechnology |
8.58%
|
|
| 3 |
₹34.58 Cr |
Pharmaceuticals & Biotechnology |
6.66%
|
|
| 4 |
₹33.57 Cr |
Pharmaceuticals & Biotechnology |
6.46%
|
|
| 5 |
₹29.71 Cr |
Pharmaceuticals & Biotechnology |
5.72%
|
|
| 6 |
₹27.77 Cr |
Healthcare Services |
5.35%
|
|
| 7 |
₹27.24 Cr |
Pharmaceuticals & Biotechnology |
5.24%
|
|
| 8 |
₹23.63 Cr |
Healthcare Services |
4.55%
|
|
| 9 |
₹21.06 Cr |
Pharmaceuticals & Biotechnology |
4.05%
|
|
| 10 |
₹17.87 Cr |
Pharmaceuticals & Biotechnology |
3.44%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.